Researchers from Embryotox, the Berlin TIS, have published their data concerning maternal fosfomycin use in pregnancy. More information can be found here. Photo by Cassidy Rowell on Unsplash
Latest Annual Conference News
Latest Teratology Studies
A sumamry of the pregnancy and lactation related enquiries made to the Belgium national Poison Centre
Associate ENTIS member Dr Michael Ceulemans and collegues from KU Leuven in Belgium have published a retrospective analysis of the pregnancy and lactation related enquiries […]
Literature review: Risk of adverse fetal effects following short-term second trimester NSAID use
Researchers from Embryotox, the Berlin TIS, have recently published the results of their systematic review focussing on the risk of prenatal ductus arteriosus constriction, oligohydramnios, […]
Population-based study of malformation risks posed by maternal antibiotic use
Researchers from the University of Southern Denmark have undertaken an analysis of the risk of congenital malformation among infants born to women who used antibiotics […]
Vulnerable populations at risk of misinformation about the safety of medicines in pregnancy
Researchers from Katholieke Universiteit Leuven in Belgium describe their experience of how Arabic-speaking pregnant women with a migration background living in Belgium are likely at risk […]
New study on perceptions of medicine use among pregnant women
Researchers from Denmark have explored perceptions of pregnant women regarding medication use during pregnancy. More information can be found here. Photo by bruce mars on Unsplash
Interesting academic highlights article discussing the FDAs pregnancy and lactation labelling rule
Pregnancy labelling of medications is a hotly debated issue in the field of teratology, and several studies have shown the limitations of providing pregnancy safety […]
Use of real-world evidence from healthcare utilization data to evaluate drug safety during pregnancy
Researchers from Boston have reviewed the important methodological considerations regarding the use of large healthcare utilization databases for drug safety surveillance in pregnancy. More information can be […]